8FD4
 
 | |
8CJP
 | | JzTx-34 toxin peptide H18A mutant | | Descriptor: | Mu-theraphotoxin-Cg1a | | Authors: | Landon, C, Meudal, H. | | Deposit date: | 2023-02-13 | | Release date: | 2023-07-26 | | Method: | SOLUTION NMR | | Cite: | Structure-function relationship of new peptides activating human Na v 1.1.
Biomed Pharmacother, 165, 2023
|
|
8CJR
 | | JzTx-34 toxin peptide W25A mutant | | Descriptor: | Mu-theraphotoxin-Cg1a | | Authors: | Landon, C, Meudal, H. | | Deposit date: | 2023-02-13 | | Release date: | 2023-07-26 | | Method: | SOLUTION NMR | | Cite: | Structure-function relationship of new peptides activating human Na v 1.1.
Biomed Pharmacother, 165, 2023
|
|
8CJS
 | | JzTx-34 toxin peptide W31A mutant | | Descriptor: | Mu-theraphotoxin-Cg1a | | Authors: | Landon, C, Meudal, H. | | Deposit date: | 2023-02-13 | | Release date: | 2023-07-26 | | Method: | SOLUTION NMR | | Cite: | Structure-function relationship of new peptides activating human Na v 1.1.
Biomed Pharmacother, 165, 2023
|
|
8CJQ
 | | JzTx-34 toxin peptide E20A mutant | | Descriptor: | Mu-theraphotoxin-Cg1a | | Authors: | Landon, C, Meudal, H. | | Deposit date: | 2023-02-13 | | Release date: | 2023-07-26 | | Method: | SOLUTION NMR | | Cite: | Structure-function relationship of new peptides activating human Na v 1.1.
Biomed Pharmacother, 165, 2023
|
|
8CIQ
 | | JzTx-34 toxin peptide | | Descriptor: | Mu-theraphotoxin-Cg1a | | Authors: | Landon, C, Meudal, H. | | Deposit date: | 2023-02-10 | | Release date: | 2023-07-26 | | Method: | SOLUTION NMR | | Cite: | Structure-function relationship of new peptides activating human Na v 1.1.
Biomed Pharmacother, 165, 2023
|
|
8CJT
 | | JzTx-34 toxin peptide W33A mutant | | Descriptor: | Mu-theraphotoxin-Cg1a | | Authors: | Landon, C, Meudal, H. | | Deposit date: | 2023-02-13 | | Release date: | 2023-07-26 | | Method: | SOLUTION NMR | | Cite: | Structure-function relationship of new peptides activating human Na v 1.1.
Biomed Pharmacother, 165, 2023
|
|
7K48
 | | Structure of NavAb/Nav1.7-VS2A chimera trapped in the resting state by tarantula toxin m3-Huwentoxin-IV | | Descriptor: | Maltose/maltodextrin-binding periplasmic protein,Ion transport protein,Sodium channel protein type 9 subunit alpha chimera, Mu-theraphotoxin-Hs2a | | Authors: | Wisedchaisri, G, Tonggu, L, Gamal El-Din, T.M, McCord, E, Zheng, N, Catterall, W.A. | | Deposit date: | 2020-09-15 | | Release date: | 2020-12-02 | | Last modified: | 2021-01-20 | | Method: | ELECTRON MICROSCOPY (3.6 Å) | | Cite: | Structural Basis for High-Affinity Trapping of the Na V 1.7 Channel in Its Resting State by Tarantula Toxin.
Mol.Cell, 81, 2021
|
|
6W6O
 | | NaChBac-Nav1.7VSDII chimera and HWTX-IV complex | | Descriptor: | (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate, Huwentoxin-IV, NaChBac-Nav1.7VSDII chimera | | Authors: | Yan, N, Gao, S. | | Deposit date: | 2020-03-17 | | Release date: | 2020-06-24 | | Last modified: | 2021-01-13 | | Method: | ELECTRON MICROSCOPY (3.2 Å) | | Cite: | Employing NaChBac for cryo-EM analysis of toxin action on voltage-gated Na + channels in nanodisc.
Proc.Natl.Acad.Sci.USA, 117, 2020
|
|
6V6T
 | |
6GFT
 | |
6MK5
 | |
5WLX
 | |
6BR0
 | | Solution NMR structure for CcoTx-I | | Descriptor: | Beta-theraphotoxin-Cm1a | | Authors: | Agwa, A.J, Schroeder, C.I. | | Deposit date: | 2017-11-29 | | Release date: | 2018-05-16 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.
J. Biol. Chem., 293, 2018
|
|
6BTV
 | | Solution NMR structures for CcoTx-II | | Descriptor: | Beta-theraphotoxin-Cm1b | | Authors: | Agwa, A.J, Schroeder, C.I. | | Deposit date: | 2017-12-07 | | Release date: | 2018-05-09 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Gating modifier toxins isolated from spider venom: Modulation of voltage-gated sodium channels and the role of lipid membranes.
J. Biol. Chem., 293, 2018
|
|
6AV8
 | |
5WE3
 | | Solution NMR structure of PaurTx-3 | | Descriptor: | Beta-theraphotoxin-Ps1a | | Authors: | Agwa, A.J, Schroeder, C.I. | | Deposit date: | 2017-07-06 | | Release date: | 2017-09-13 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Lengths of the C-Terminus and Interconnecting Loops Impact Stability of Spider-Derived Gating Modifier Toxins.
Toxins (Basel), 9, 2017
|
|
5T3M
 | |
5I2P
 | |
5TLR
 | | Solution NMR structure of gHwTx-IV | | Descriptor: | Mu-theraphotoxin-Hs2a | | Authors: | Agwa, A.J, Schroeder, C.I. | | Deposit date: | 2016-10-11 | | Release date: | 2017-02-22 | | Last modified: | 2023-06-14 | | Method: | SOLUTION NMR | | Cite: | Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7.
Biochim. Biophys. Acta, 1859, 2017
|
|
5I1X
 | |
2N6O
 | |
5EPM
 | |
2N1N
 | | Solution structure of VSTx1 | | Descriptor: | Kappa-theraphotoxin-Gr3a | | Authors: | Lau, H.Y, King, G.F, Mobli, M. | | Deposit date: | 2015-04-12 | | Release date: | 2016-03-02 | | Last modified: | 2016-10-12 | | Method: | SOLUTION NMR | | Cite: | Molecular basis of the interaction between gating modifier spider toxins and the voltage sensor of voltage-gated ion channels.
Sci Rep, 6
|
|
2MXO
 | |
